Hydroxy Compound Active Ingredients TRIZ Cases

Ozonized unsaturated oils increase cutaneous cannabidiol penetration, enabling effective anti-wrinkle action at lower doses to avoid high costs.

CYP26B1 inhibitors prevent enzymatic degradation of endogenous retinoic acid, reducing toxicity while sustaining therapeutic efficacy.

Polyunsaturated fatty acid monoglycerides increase cannabinoid bioavailability via intestinal lymphatic transport while minimizing psychotropic effects.

Silica microcapsules protect tretinoin from benzoyl peroxide degradation, maintaining stability for acne treatment.

Mannitol stabilizes volatile (+)-2-borneol while copovidone enables rapid release, achieving high bioavailability without injection.

Whole plant cannabis substrates resolve contradictions between growth reliability and precise CBD:THC ratios through composite material principles.

A pharmaceutical spray combines humectants and film-forming agents to provide prolonged oral lubrication.

A topical vaginal care composition targets genetic changes in the introitus and labia using specific botanical extracts.

Low-dose naltrexone pre-treatment increases CB2 receptor levels, enabling effective cannabinoid therapy while avoiding psychotropic side effects.

A shelf-stable composition blends coconut oil, clarified butter, and lecithin to enhance cannabinoid bioavailability.

Oleic acid mediates duodenal absorption of cannabidiol, resolving poor oral bioavailability to sustain plasma concentrations.

Purified cannabidiol replaces mTOR inhibitors to reduce tumour burden while avoiding unacceptable side effect profiles.

A sympathomimetic-free nasal spray formulation uses menthol and humectants to soothe irritated tissue.

Phosphate buffer and antioxidant stabilize sandalwood oil cream formulations, preventing discoloration and maintaining therapeutic efficacy over time.

A transdermal patch composition uses a specific solvent blend to enhance drug absorption.

A non-racemic mixture of R-beta-hydroxybutyrate and S-beta-hydroxybutyrate elevates ketone body levels.

Topical citric acid and sodium bicarbonate solution raises tissue alkalinity to eliminate fibrin and reduce pain without toxic absorption risks.

Bisfluoroalkyl-1,4-benzodiazepinone compounds inhibit Notch signaling pathways to suppress adenoid cystic carcinoma tumor growth.

Vitis Vinifera extract and resveratrol protect L-ascorbic acid from oxidation, enabling stable high-concentration cosmetic compositions.

Combining p53-engineered dendritic cells with ATRA and checkpoint inhibitors extends median survival in small cell lung cancer.

Oral plant extract composition treats metabolic arthritis, replacing injectable therapies to improve patient compliance and reduce toxicity.

Olivetol competitively inhibits CB1 and CB2 receptors, reducing THC psychotropic effects while maintaining therapeutic benefits.

Anhydrous hydrogel delivers cannabinoids and stabilized menthol to the oral cavity, resolving water sensitivity in moisture-sensitive environments.

Polyphenolic agents in dialysis fluid reduce cytotoxicity and fibrosis caused by high glucose concentrations.

An antioxidant protects the stilbene from oxidation while an inert environment prevents photo degradation, maintaining chemical stability.

A water-soluble iodine preparation stabilizes the ethanol mixture, preventing separation while enabling precise radiographic tracing during embolization.

Banaba extract and inositol composition reduces hyperandrogenism without hormonal side effects.

A dietary supplement composition merges hydroxytyrosol, fish oil EPA/DHA, and curcumin to lower C-reactive protein levels in breast cancer patients.

Polyvinyl acetate plasticizers in the gum base resolve the contradiction between prolonged cannabinoid release duration and deteriorating sensory properties.

Negative photoresist patterning creates precise diffraction gratings for waveguide displays.

Antisolvent crystallization yields stable cannabidivarin enantiomers, resolving the trade-off between pharmaceutical reliability and manufacturing complexity.

Anhydrous hydrogel delivers cannabinoids and menthol, avoiding moisture sensitivity that limits traditional gels.

Sequential administration of cannabinoids after chemotherapeutic agents suppresses breast cancer cell viability through targeted elimination of residual tumor cells.

Novel bridged bicycloalkyl aminothiazole compounds selectively inhibit CDK9 kinase activity to treat various cancers.